Home › Galena Biopharma Raised to "Outperform" at Oppenheimer
 

Keywords :   


Galena Biopharma Raised to "Outperform" at Oppenheimer

2015-11-15 17:14:57| Biotech - Topix.net

The brokerage currently has a $4.00 price target on the biotechnology company's stock. Oppenheimer's target price suggests a potential upside of 166.67% from the company's previous close.

Tags: raised outperform oppenheimer biopharma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »